Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - ENANTA PHARMACEUTICALS INC | d401292ds1a.htm |
| EX-3.3 - EX-3.3 - ENANTA PHARMACEUTICALS INC | d401292dex33.htm |
| EX-5.1 - EX-5.1 - ENANTA PHARMACEUTICALS INC | d401292dex51.htm |
| EX-3.4 - EX-3.4 - ENANTA PHARMACEUTICALS INC | d401292dex34.htm |
| EX-3.5 - EX-3.5 - ENANTA PHARMACEUTICALS INC | d401292dex35.htm |
| EX-10.8 - EX-10.8 - ENANTA PHARMACEUTICALS INC | d401292dex108.htm |
| EX-10.5 - EX-10.5 - ENANTA PHARMACEUTICALS INC | d401292dex105.htm |
| EX-10.9 - EX-10.9 - ENANTA PHARMACEUTICALS INC | d401292dex109.htm |
| EX-10.13 - EX-10.13 - ENANTA PHARMACEUTICALS INC | d401292dex1013.htm |
| EX-10.10 - EX-10.10 - ENANTA PHARMACEUTICALS INC | d401292dex1010.htm |
| EX-10.14 - EX-10.14 - ENANTA PHARMACEUTICALS INC | d401292dex1014.htm |
| EX-10.15 - EX-10.15 - ENANTA PHARMACEUTICALS INC | d401292dex1015.htm |
| EX-10.17 - EX-10.17 - ENANTA PHARMACEUTICALS INC | d401292dex1017.htm |
| EX-10.11 - EX-10.11 - ENANTA PHARMACEUTICALS INC | d401292dex1011.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Amendment No. 4 to the Registration Statement on Form S-1 of Enanta Pharmaceuticals, Inc. of our report dated November 16, 2012, except for Note 21, as to which the date is March 4, 2013, relating to the financial statements of Enanta Pharmaceuticals, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 4, 2013